Your browser doesn't support javascript.
loading
An LTR Retrotransposon-Derived Long Noncoding RNA lncMER52A Promotes Hepatocellular Carcinoma Progression by Binding p120-Catenin.
Wu, Yangjun; Zhao, Yiming; Huan, Lin; Zhao, Jingjing; Zhou, Yuqiang; Xu, Linguo; Hu, Zhixiang; Liu, Yizhe; Chen, Zhiao; Wang, Lu; Huang, Shenglin; He, Xianghuo; Liang, Linhui.
Affiliation
  • Wu Y; Fudan University Shanghai Cancer Center, Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Zhao Y; Department of Hepatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Huan L; Fudan University Shanghai Cancer Center, Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Zhao J; Fudan University Shanghai Cancer Center, Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Zhou Y; Fudan University Shanghai Cancer Center, Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Xu L; Fudan University Shanghai Cancer Center, Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Hu Z; Fudan University Shanghai Cancer Center, Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Liu Y; Fudan University Shanghai Cancer Center, Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Chen Z; Fudan University Shanghai Cancer Center, Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Wang L; Department of Hepatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Huang S; Fudan University Shanghai Cancer Center, Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, China. lianglinhui@fudan.edu.cn xhhe@fudan.edu.cn slhuang@fudan.edu.cn.
  • He X; Fudan University Shanghai Cancer Center, Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, China. lianglinhui@fudan.edu.cn xhhe@fudan.edu.cn slhuang@fudan.edu.cn.
  • Liang L; Fudan University Shanghai Cancer Center, Key Laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Fudan University, Shanghai, China. lianglinhui@fudan.edu.cn xhhe@fudan.edu.cn slhuang@fudan.edu.cn.
Cancer Res ; 80(5): 976-987, 2020 03 01.
Article in En | MEDLINE | ID: mdl-31874857
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Biomarkers, Tumor / Carcinoma, Hepatocellular / Catenins / RNA, Long Noncoding / Liver Neoplasms Type of study: Prognostic_studies Language: En Journal: Cancer Res Year: 2020 Type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Biomarkers, Tumor / Carcinoma, Hepatocellular / Catenins / RNA, Long Noncoding / Liver Neoplasms Type of study: Prognostic_studies Language: En Journal: Cancer Res Year: 2020 Type: Article Affiliation country: China